Navigation Links
At the 2007 Alzheimer's Association International Conference on the,Prevention of Dementia - Neurochem's U.S. Principal Investigator,Presents Update on Tramiprosate (Alzhemed)

tual results may vary once the final and quality-controlled verification of data and analyses has been completed, the expense and uncertainty of obtaining regulatory approval, including from the FDA, and the possibility of having to conduct additional clinical trials. Further, even if regulatory approval is obtained, therapeutic products are generally subject to: stringent on-going governmental regulation, challenges in gaining market acceptance, and competition. Neurochem does not undertake any obligation to publicly update its forward-looking statements, whether as a result of new information, future events, or otherwise. Please see the Annual Information Form for further risk factors that might affect the Company and its business.

    For further information, please contact:


    Lise Hebert, PhD                          Tel: (450) 680-4572

    Vice President, Corporate Communications  

lhebert@neurochem.com

CONTACT: Lise Hebert, PhD, Vice President, Corporate Communications, (450)680-4572, lhebert@neurochem.com

Ticker Symbol: (:NRM.),(:NRMX)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3 4

Related medicine technology :

1. Samaritans Alzheimers Drug Caprospinol Suggests Brain May be Able to Heal From Alzheimers Disease
2. Resveratrol Studies Suggest Broad Implications for SIRT1 Activation in Neurodegenerative Diseases of Aging Such as Alzheimers Disease
3. Accera, Inc. Announces Open-Label Data from Phase II Study in Alzheimers Disease at International Conference on Prevention of Dementia
4. Myriad Genetics Presents Mathematical Comparison of Disease Modification Trial Designs at Alzheimers ConferenceCurrent Flurizan Phase 3 Study Design May Demonstrate Disease Modification
5. Treating Heart Disease Risk Factors May Slow Alzheimers Disease Progression
6. Medivations Dimebon Maintains Statistically Significant Benefit on All Five Efficacy Endpoints in Alzheimers Disease Trial After One Year of Therapy
7. Clinical Update - Debio 9902 (ZT-1) for Alzheimers Disease
8. Medivation to Host Conference Call to Discuss Top-Line 12-Month Results From Dimebon Alzheimers Disease Study
9. Medivation Announces Presentation of New Subset Analyses From Dimebon Phase 2 Alzheimers Disease Trial at American Academy of Neurology Annual Meeting
10. Ceregene Presents Interim Phase 1 Clinical Data of CERE-110 for the Treatment of Alzheimers Disease
11. Samaritan Announces Positive Data in Nonclinical (IND) In-Vitro Studies for Promising Alzheimers Drug
Post Your Comments:
(Date:11/21/2014)... 2014  World Hemp Oil, an importer of oil ... are now offering legal, organic oil with high CBD ... grown in medical marijuana states. People suffering from epileptic ... Parkinson,s, MS, and spinal cord injury, no longer have ... imported CBD Oil Is legal in all states. ...
(Date:11/21/2014)... , 21. November 2014 /PRNewswire/ ... hat heute bekannt gegeben, dass die ... EMA) die Kennzeichnung als Orphan-Medizinprodukt an ... des Unternehmens zur Behandlung von Fibrodysplasia ... seltene, stark beeinträchtigende genetische Krankheit, die ...
(Date:11/21/2014)...  Market research firm Kalorama information says that 2014 ... in the medical device industry.  The firm thinks the ... just 3% growth this year, which led firms to ... lines and entrance by acquisition into new competitive zones. ... The Global Market for Medical Devices, 5 th ...
Breaking Medicine Technology:New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 2New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 3Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 2Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 3Kalorama: 2014 The "Year of The Buy" in Medical Device Industry 2
... COLUMBUS, Ohio, June 1, 2011 EndoSphere Inc., a ... devices for the treatment of metabolic diseases, including obesity ... a highly oversubscribed Series A Preferred Financing round led ...  EndoSphere Inc., which holds 23 U.S. and international issued ...
... 2011 Mettler-Toledo International Inc. (NYSE: MTD ) ... Global Healthcare Conference in New York on Wednesday, June 8, ... webcast of the presentation, visit the investor relations page on ... of the webcast will be available for seven days. ...
Cached Medicine Technology:EndoSphere Inc. Announces Pivotal Financing Led by Broadline Capital 2
(Date:11/23/2014)... Pro Ace Care, a renowned Vancouver hot water tank company, ... 8 year warranty on its selected hot water tanks. As ... to the impending winter season, it was important for Pro ... that the company provides. As a result, Pro Ace will ... Bradford hot water tanks. , “Every installer who works ...
(Date:11/23/2014)... 2014 (HealthDay News) -- The holidays can be a ... overload can trigger major meltdowns, an expert says. ... of circumstances, but when you have children with special ... occupational therapy professor at University of the Sciences in ... best to let your hosts or visitors know what ...
(Date:11/23/2014)... To show thanks to new and old ... white evening dresses for weddings. Customers who need ... iFitDress.com is a distinguished dress manufacturer, and it is among ... customers for a very long time. The CEO of this ... will be able to buy not only a beautiful dress, ...
(Date:11/23/2014)... AngelWeddingDress.com has recently updated its online store, ... dresses. “If you are looking for gorgeous beach wedding ... possible. Here you can enjoy 70% off discounts and ... a big marriage ceremony is the most important dream ... dress is uppermost priority. Ophelia, one of customers, said, ...
(Date:11/23/2014)... The FDA is Watching: , What ... Webinar**, Dec. 11, 2014 ? Any Time at Your ... on promotional activities is no longer limited to magazine ... at websites, Twitter, journal articles, TV appearances, Facebook and ... 11, for On-Demand access to Timothy Ayers and Michelle ...
Breaking Medicine News(10 mins):Health News:Pro Ace Care Now Gives 8 Year Guarantee on Selected Vancouver Hot Water Tanks 2Health News:Holidays Can Be Sensory Overload for Kids With Autism 2Health News:iFitDress.com: Wonderful White Evening Dresses Now Available 2Health News:Beach Wedding Dresses Added to Outstanding Online Dress Company AngelWeddingDress.com 2Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 2Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 3Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 4Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 5
... A parliamentary panel has recommended that the Indian Army ... to de-stress them.// ,"There is also imperative need ... de-stress our jawans in field units. Immediate steps may ... defence said in its "Review of medical services and ...
... and flossing. A new study in published in the ... common tasks are vital. In the study, researchers found ... flossing routinely was responsible for 38 percent reduction in ... reduced. In the group that did not floss as ...
... yes; but researchers say it could also keep brain ... were found to boost brain activity in much the ... of Massachusetts Lowell (UML). The animal research found that ... brain of the essential neurotransmitter acetylcholine. This in turn ...
... asked the present generation not to be under the wrong ... cured//. ,They said that the anti retroviral (ARV) ... the worst side effects of the ARVs. The drugs prescribed ... off ARVs. All these drugs have different toxicity levels and ...
... Medication in treating major depression is only one of ... a newly published UCLA study.// ,Published ... of Psychiatry, the study used electroencephalogram (EEG) measurements to ... changes in brain activity during a placebo lead-in phase ...
... been linked to an increased risk of stroke in ... which has added to the growing evidence of possible ... which appear in the August issue of Human Molecular ... 100 percent depending on the particular genetic variation. ...
Cached Medicine News:Health News:Yoga to De-stress Indian Army Soldiers 2Health News:Apple Juice May Keep Alzheimer's Away 2Health News:Depression - a Puzzle of Many Pieces 2Health News:Stroke Risk Higher with Gene Variations 2
The Select 3D Arterial cannulae from Medtronic features a tip configuration which diffuses the flow through multiple outlets. This unique tip design provides reduced velocity with one central and thr...
The Medtronic EOPA CAP® arterial cannula provides a simple solution to obtaining accurate arterial pressure readings....
Intermittent catheter...
Intermittent catheter...
Medicine Products: